Cargando…

A Proposed Framework for Patient-Focused Policy at the U.S. Food and Drug Administration

Medical product sponsors are encouraged to include the patient perspective in their medical product development strategy to inform product design, augment regulatory submissions, argue for alternative clinical trial designs, or to support indications in specific patient populations. The goal is to c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kuehn, Carrie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784212/ https://www.ncbi.nlm.nih.gov/pubmed/31461892 http://dx.doi.org/10.3390/biomedicines7030064

Ejemplares similares

Proposed U.S. regulation of gene-edited food animals is not fit for purpose
por: Van Eenennaam, Alison L., et al.
Publicado: (2019)

US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
por: Shord, Stacy S., et al.
Publicado: (2023)

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018
por: Cook, Jack, et al.
Publicado: (2020)

Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
por: Sabbagh, Marwan N., et al.
Publicado: (2023)

Of risks and regulations: how leading U.S. nanoscientists form policy stances about nanotechnology
por: Corley, Elizabeth A., et al.
Publicado: (2009)

The U.S. Food and Drug Administration: Drug Information Resource for Formulary Recommendations
por: Marchand, Heidi C., et al.
Publicado: (2012)

The Significance of Information Posted on the U.S. Food and Drug Administration’s Website
por: Cook, G. Elliott, et al.
Publicado: (2013)

Towards a conceptual framework for addressing state-level barriers to decentralized clinical trials in the U.S.
por: Zawada, Stephanie J., et al.
Publicado: (2023)

The Role of Partnerships in U.S. Food Policy Council Policy Activities
por: Clayton, Megan L., et al.
Publicado: (2015)

Vinyl Chloride and U.S. EPA Research
por: Price, Courtney M.
Publicado: (2005)

How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
por: Furlong, Pat, et al.
Publicado: (2015)

Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.
por: Zoon, K C
Publicado: (1999)

Why the Watchdog Won’t Bite: U.S. Food and Drug Administration Challenges
por: Lex, Joe
Publicado: (2016)

Polysubstance use in the U.S. opioid crisis
por: Compton, Wilson M., et al.
Publicado: (2020)

Monitoring for Asbestos: U.S. EPA Methods
por: Callahan, Kathleen C.
Publicado: (2004)

U.S. PBDE Levels: Effects in Mice
por: Cleet, Christopher
Publicado: (2004)

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey
por: DiStefano, Michael J., et al.
Publicado: (2022)

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations
por: Zuabi, Nadia, et al.
Publicado: (2016)

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
por: Inglesby, Thomas V., et al.
Publicado: (2020)

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
por: Hirshberg, Boaz, et al.
Publicado: (2011)

Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration
por: Sullivan, Helen W., et al.
Publicado: (2016)

Appropriate Nurse Staffing Levels for U.S. Nursing Homes
por: Harrington, Charlene, et al.
Publicado: (2020)

U.S. Refugee Resettlement Is in Ruins—It Is Our Duty to Rebuild It
por: Lorenz, Matthew L.
Publicado: (2022)

U.S. Sperm Trend: Response
por: Heinze, John
Publicado: (1999)

U.S. EPA’s Toxicity Reference Database: Martin and Dix Respond
por: Martin, Matthew T., et al.
Publicado: (2009)

Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
por: Abulwerdi, Gelareh A., et al.
Publicado: (2023)

POLICIES AND PREVENTION OF U.S. WOMEN’S VIOLENT DEATH ACROSS AGES
por: Salari, Sonia L, et al.
Publicado: (2019)

US state policies for Medicaid coverage of donor human milk
por: Rose, Allison T., et al.
Publicado: (2022)

Priority-based assessment of food additives database of the U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition.
por: Benz, R D, et al.
Publicado: (1991)

U.S. Food and Drug Administration-Certified Food Dyes as Organocatalysts in the Visible Light-Promoted Chlorination of Aromatics and Heteroaromatics
por: Rogers, David A., et al.
Publicado: (2020)

Flawed Ethics Recommendations of the U.S. EPA’s Human Studies Review Board
por: Shrader-Frechette, Kristin
Publicado: (2007)

Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like
por: Marble, Hetal D., et al.
Publicado: (2021)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework
por: Saini, Kamal S., et al.
Publicado: (2021)

Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food & Drug Administration
por: Rappel, MJ, et al.
Publicado: (2017)

U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment.
por: Gaylor, D W, et al.
Publicado: (1998)

Recognize fish as food in policy discourse and development funding
por: Bennett, Abigail, et al.
Publicado: (2021)

Exposure to Environmental Tobacco Smoke and Cognitive Abilities Among U.S. Children and Adolescents
por: Petersen, Phillip
Publicado: (2005)

Risk perceptions starting to shift? U.S. citizens are forming opinions about nanotechnology
por: Priest, Susanna, et al.
Publicado: (2009)

The Importance of the Global Health Strategy from the U.S. Department of Health and Human Services
por: Daulaire, Nils
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k6shm5hp8v9omtkfii06eiao8u